Skip to contentA
Abbott Laboratories
A
ABTAbbott Laboratories Q1 2015 · 10-Q
Revenue$4.90B$4.90B+3.0% vs Q1 2014 Net Income$2.29B$2.29B+511.2% vs Q1 2014 EPS Diluted$1.51$1.51+529.2% vs Q1 2014 Gross Profit$2,660,000,000+13.0% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Abbott Laboratories · CIK 1800 · Engraved from SEC EDGAR
Operating Cash Flow$2,000,000−99.4% Free Cash Flowderived-$233,000,000N/M Margins · derivedGross margin54.3%+4.8 pt vs Q1 2014
Operating margin12.5%+4.8 pt vs Q1 2014
Net margin46.8%+38.9 pt vs Q1 2014
ended Mar 31, 2015 · filed May 6, 2015 · 36 d after period end